Insider Shareholders with Direct Ownership of Aprea Therapeutics, Inc. (APRE)
This section provides a comprehensive overview of the insiders with direct ownership of Aprea Therapeutics, Inc. (APRE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Aprea Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Oren Gilad
President/CEO |
6,161,025 | 0 | 333,395 $960,177 | 9 |
Oct 23, 2024
Added 0.15%
|
|
Christian S Schade
Director |
335,500 | 87,414 | 259,246 $746,628 | 6 |
Jul 28, 2022
Added 11.11%
|
|
Marc Duey
Director |
4,047,420 | 6,462 | 233,651 $672,914 | 7 |
Oct 18, 2024
Reduced 2.69%
|
|
Scott M Coiante
SVP, Chief Financial Officer |
200,200 | 57,635 | 145,065 $417,787 | 6 |
Jul 28, 2022
Added 29.53%
|
|
Eyal C. Attar
SVP, Chief Medical Officer |
150,900 | 93,667 | 57,233 $164,831 | 6 |
Jun 03, 2022
Reduced 36.34%
|
|
Gregory Alan Korbel
SVP, Chief Operating Officer |
175,300 | 130,038 | 45,762 $131,794 | 17 |
Jul 28, 2022
Added 34.68%
|
|
Bernd R. Seizinger
Director |
89,107 | 0 | 44,730 $128,822 | 9 |
Oct 11, 2024
Added 18.27%
|
|
Lars B. Abrahmsen
SVP, Chief Scientific Officer |
118,700 | 75,000 | 43,700 $125,856 | 6 |
Mar 10, 2022
Added 36.11%
|
|
John P. Hamill
SrVP/CFO/Prin Fin & Acct Ofcr |
275,754 | 0 | 19,368 $55,779 | 6 |
Oct 11, 2024
Added 0.26%
|
|
Gregory S. Wessels
SVP, Chief Commercial Officer |
16,000 | 0 | 16,000 $46,080 | 1 |
Feb 25, 2021
Added 50.0%
|
|
John B Henneman Iii
Director |
19,010 | 0 | 9,184 $26,449 | 5 |
Jun 20, 2024
Added 10.22%
|
|
Nadeem Q. Mirza
Chief Medical Officer |
6,730 | 0 | 6,730 $19,382 | 1 |
May 01, 2024
Added 50.0%
|
|
Michael Aaron Kelly
Director |
4,610 | 0 | 4,610 $13,276 | 1 |
Jun 30, 2021
Added 50.0%
|
|
Fouad Namouni
Director |
4,610 | 0 | 4,610 $13,276 | 1 |
Jun 30, 2021
Added 50.0%
|
|
Rifat Pamukcu
Director |
56,820 | 0 | 4,401 $12,674 | 4 |
Jun 20, 2024
Added 19.19%
|
|
Richard Peters
Director |
12,150 | 0 | 2,074 $5,973 | 4 |
Jun 20, 2024
Added 33.5%
|
|
Michael Grissinger
Director |
7,540 | 0 | 1,844 $5,310 | 3 |
Jun 20, 2024
Added 36.17%
|